A blood test that detects carcinoembryonic antigen (CEA) can improve preoperative risk stratification for patients with stage II colon cancer and guide decisions about adjuvant chemotherapy, say ...
Assessing Surveillance Utilization and Value in Commercially Insured Patients With Colorectal Cancer
Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...
Molecular landscape of colorectal cancers harboring R-spondin fusions. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not include a full text component.
Results underscore clinical utility of novel circulating tumor DNA assay to detect disease recurrence Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results